These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
402 related items for PubMed ID: 19947892
1. Pharmacology and clinical use of voriconazole. Thompson GR, Lewis JS. Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):83-94. PubMed ID: 19947892 [Abstract] [Full Text] [Related]
2. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Fera MT, La Camera E, De Sarro A. Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707 [Abstract] [Full Text] [Related]
3. Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections. Cecil JA, Wenzel RP. Expert Rev Hematol; 2009 Jun; 2(3):237-54. PubMed ID: 21082966 [Abstract] [Full Text] [Related]
4. Therapeutic drug monitoring of voriconazole. Brüggemann RJ, Donnelly JP, Aarnoutse RE, Warris A, Blijlevens NM, Mouton JW, Verweij PE, Burger DM. Ther Drug Monit; 2008 Aug; 30(4):403-11. PubMed ID: 18641555 [Abstract] [Full Text] [Related]
5. Voriconazole: a new triazole antifungal agent. Johnson LB, Kauffman CA. Clin Infect Dis; 2003 Mar 01; 36(5):630-7. PubMed ID: 12594645 [Abstract] [Full Text] [Related]
6. Voriconazole. UK 109496. Drugs R D; 1999 Feb 01; 1(2):187-8. PubMed ID: 10566023 [No Abstract] [Full Text] [Related]
7. Voriconazole -- better chances for patients with invasive mycoses. Ghannoum MA, Kuhn DM. Eur J Med Res; 2002 May 31; 7(5):242-56. PubMed ID: 12069915 [Abstract] [Full Text] [Related]
8. Voriconazole : a review of its use in the management of invasive fungal infections. Scott LJ, Simpson D. Drugs; 2007 May 31; 67(2):269-98. PubMed ID: 17284090 [Abstract] [Full Text] [Related]
9. Voriconazole: therapeutic review of a new azole antifungal. Herbrecht R. Expert Rev Anti Infect Ther; 2004 Aug 31; 2(4):485-97. PubMed ID: 15482215 [Abstract] [Full Text] [Related]
10. Pharmacoeconomics of voriconazole in the management of invasive fungal infections. Al-Badriyeh D, Heng SC, Neoh CF, Slavin M, Stewart K, Kong DC. Expert Rev Pharmacoecon Outcomes Res; 2010 Dec 31; 10(6):623-36. PubMed ID: 21155694 [Abstract] [Full Text] [Related]
11. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients. Berge M, Guillemain R, Boussaud V, Pham MH, Chevalier P, Batisse A, Amrein C, Dannaoui E, Loriot MA, Lillo-Le Louet A, Billaud EM. Transpl Infect Dis; 2009 Jun 31; 11(3):211-9. PubMed ID: 19302272 [Abstract] [Full Text] [Related]
14. [Level of evidence for therapeutic drug monitoring of voriconazole]. Hulin A, Dailly E, Le Guellec C, Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Therapie; 2011 Jun 31; 66(2):109-14. PubMed ID: 21635857 [Abstract] [Full Text] [Related]
16. Therapeutic drug monitoring of voriconazole and posaconazole. Hussaini T, Rüping MJ, Farowski F, Vehreschild JJ, Cornely OA. Pharmacotherapy; 2011 Feb 31; 31(2):214-25. PubMed ID: 21275497 [Abstract] [Full Text] [Related]
17. [Voriconazole: a new weapon against invasive fungal infections]. Aoun M. Rev Med Brux; 2004 Jun 31; 25(3):166-71. PubMed ID: 15291449 [Abstract] [Full Text] [Related]
18. Therapeutic drug monitoring for triazoles. Hope WW, Billaud EM, Lestner J, Denning DW. Curr Opin Infect Dis; 2008 Dec 31; 21(6):580-6. PubMed ID: 18978525 [Abstract] [Full Text] [Related]
19. Pharmacokinetic/pharmacodynamic profile of voriconazole. Theuretzbacher U, Ihle F, Derendorf H. Clin Pharmacokinet; 2006 Dec 31; 45(7):649-63. PubMed ID: 16802848 [Abstract] [Full Text] [Related]